Aquestive Therapeutics (AQST) EBITDA Margin (2017 - 2026)
Aquestive Therapeutics (AQST) posted EBITDA Margin of -58.52% for Q2 2026, up 53.73 percentage points from -112.25% a year earlier but down 30.20 percentage points from the prior quarter.
Aquestive Therapeutics (AQST) EBITDA Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Aquestive Therapeutics was -96.56%, up 21.31 percentage points year-over-year; for FY2025, it came in at -158.27%, down 106.06 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -72.23 percentage points (FY2020 to FY2025).
- In prior years, Aquestive Therapeutics' EBITDA Margin was -52.21% in FY2024 (-25.01 pp), -27.20% in FY2023 (+56.02 pp), -83.22% in FY2022 (-20.83 pp) and -62.39% in FY2021 (+23.65 pp).
- Quarterly EBITDA Margin has run from a low of -220.58% in Q4 2025 to a high of 1.29% in Q2 2024 over five years.
- On a year-over-year basis, EBITDA Margin increased in two of the last eight quarters, with an average year-over-year change of -35.29 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2026, with a gain of 192.16 percentage points; the weakest was Q1 2025, with a drop of 147.89 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -28.32% (Q1 2026), -220.58% (Q4 2025) and -88.55% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Aquestive Therapeutics | 586.14 Mn | 126.68 Mn | 9.80 Mn | -58.52% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.52% |
| Mar 31, 2026 | -28.32% |
| Dec 31, 2025 | -220.58% |
| Sep 30, 2025 | -88.55% |
| Jun 30, 2025 | -112.25% |
| Mar 31, 2025 | -220.48% |
| Dec 31, 2024 | -113.19% |
| Sep 30, 2024 | -60.04% |
| Jun 30, 2024 | 1.29% |
| Mar 31, 2024 | -72.60% |
| Dec 31, 2023 | -26.08% |
| Sep 30, 2023 | -16.25% |
| Jun 30, 2023 | -29.61% |
| Mar 31, 2023 | -38.44% |
| Dec 31, 2022 | -96.57% |
| Sep 30, 2022 | -72.03% |
| Jun 30, 2022 | -91.18% |
| Mar 31, 2022 | -73.44% |
| Dec 31, 2021 | -98.74% |
| Sep 30, 2021 | -54.43% |
Aquestive Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();